Details of the Drug

General Information of Drug (ID: DMZHL2T)

Drug Name

XmAB24306

Synonyms

RG6323

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Recombinant protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04250155) An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.